Intestinal failure-associated liver disease in hospitalised children. Issue 3 (13th January 2012)

• Record Type: Journal Article
• Authors: Pichler, Judith; Horn, Venetia; Macdonald, Sarah; Hill, Susan
• Is Part Of: Archives of disease in childhood. Volume 97:Issue 3(2012)
• Page Start: 211
• Page End: 214
• Publication Date: 2012-01-13
• Subjects: Children -- Diseases -- Periodicals; Infants -- Diseases -- Periodicals; 618.920005
• DOI: 10.1136/archdischild-2011-300274
• Languages: English
• ISSNs: 0003-9888

Abstract

Abstract : Objective and aim: Liver disease is a potentially life-threatening complication of intravenous/parenteral nutrition (PN). Our aim was to determine the incidence, aetiology and outcome of intestinal failure-associated liver disease (IFALD) in hospitalised children treated with long-term PN (>27 days). Methods: Over 4 years all long-term intestinal failure (IF) patients were reviewed for the possible predisposing factors of age, diagnosis, PN lipid, sepsis, length of PN treatment and length of hospitalisation. Outcome measures were IFALD incidence, severity and prognosis. Results: Of 60/279 (22%) children aged 0–18 years who developed IFALD, 13 (5%) progressed to type 3/end stage disease. IFALD was associated with younger age (p=0.03), longer treatment (p<0.001), longer hospitalisation (p=0.01), surgical diagnosis (p=0.005) and prematurity (p=0.03). IFALD was not associated with sepsis. Intestinal surgery was associated with IFALD independently of age (p=0.03). Survival was 86%, with three deaths attributed to IFALD (1% of all cases), all of which were surgical. Conclusion: IFALD incidence was lower than previously reported in paediatric patients, with surgical neonates at greatest risk.